Surface coatings of ZnO nanoparticles mitigate differentially a host of transcriptional, protein and signalling responses in primary human olfactory cells

Particle and Fibre Toxicology

Volumn 10, Issue 1, 2013, Pages

  Osmond McLeod, Megan J ^a   Osmond, Ronald I W ^b   Oytam, Yalchin ^a   McCall, Maxine J ^a   Feltis, Bryce ^c,d   Mackay Sim, Alan ^e   Wood, Stephen A ^e   Cook, Anthony L ^e,f  

^a CSIRO   (Australia)

^b TGR BioSciences   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cell signalling; DNA damage; Gene expression; Nanoparticle; Olfactory; Zinc oxide

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE; ZINC OXIDE NANOPARTICLE;

ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL METABOLISM; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MATERIAL COATING; MEMBRANE MICROPARTICLE; OLFACTORY EPITHELIUM; OLFACTORY NEUROSPHERE DERIVED CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

RATTUS;

CULTURE MEDIA; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; OLFACTORY MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; TRANSCRIPTION, GENETIC; ZINC OXIDE;

EID: 84886168023     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-10-54     Document Type: Article

References (60)

1. Wang ZL. Zinc oxide nanostructures: growth, properties and applications. J Phys Condens Matter 2004, 16:R829-R858.
2. Mitchnick MA, Fairhurst D, Pinnell SR. Microfine zinc oxide (z-cote) as a photostable UVA/UVB sunblock agent. J Am Acad Dermatol 1999, 40:85-90. 10.1016/S0190-9622(99)70532-3, 9922017.
3. Wolf R, Wolf D, Morganti P, Ruocco V. Sunscreens. Clin Dermatol 2001, 19:452-459. 10.1016/S0738-081X(01)00190-0, 11535388.
4. Osmond MJ, McCall MJ. Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotox 2010, 4:15-41.
5. Kelleher P, Pacheco K, Newman L. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 2000, 108:685-696.
6. Kao Y-Y, Chen Y-C, Cheng T-J, Chiung Y-M, Liu P-S. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Tox Sci 2012, 125:462-472.
7. Cho W-S, Duffin R, Howie S, Scotton C, Wallace W, MacNee W, Bradley M, Megson I, Donaldson K. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol 2011, 8:27. 10.1186/1743-8977-8-27, 3179432, 21896169.
8. Cho W-S, Duffin R, Poland C, Duschl A, Oostingh GJ, MacNee W, Bradley M, Megson I, Donaldson K. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotox 2012, 6:22-35.
9. Vandebriel R, Jong WD. A review of mammalian toxicity of ZnO nanoparticles. Nanotech Sci App 2012, 5:61-71.
10. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect 2007, 115:403-409. 10.1289/ehp.115-a403, 1849911, 17431490.
11. Lai JCK, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibrosis. Internat J Nanomed 2008, 3:533-545.
12. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134. 10.1021/nn800511k, 19206459.
13. Deng X, Luan Q, Chen W, Wang Y, Wu M, Zhang H, Jiao Z. Nanosized zinc oxide particles induce neural stem cell apopotosis. Nanotechnology 2009, 20:115101. 10.1088/0957-4484/20/11/115101, 19420431.
14. Jeng H, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A 2006, 41:2699-2711.
15. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Early pulmonary cytokine responses to zinc oxide fume inhalation. Environ Res 1997, 75:7-11. 10.1006/enrs.1997.3765, 9356189.
16. Gordon T, Chen LC, Fine JM, Schlesinger RB, Su WY, Kimmel TA, Madur MO. Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am Ind Hyg Assoc J 1992, 53:503-509. 10.1080/15298669291360030, 1509990.
17. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Beckett W. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. J Occup Environ Med 1997, 39:722-726. 10.1097/00043764-199708000-00006, 9273875.
18. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Sparer J, Beckett WS. Characterization of clinical tolerance to inhaled zinc oxide in naive subjects and sheet metal workers. J Occup Environ Med 2000, 42:1085-1091. 10.1097/00043764-200011000-00010, 11094787.
19. Wang S, Tooley I. Photoprotection in the era of nanotechnology. Semin Cutan Med Surg 2011, 30:210-213. 10.1016/j.sder.2011.07.006, 22123418.
20. Yin H, Casey PS, McCall MJ, Fenech M. Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles. Langmuir 2010, 26:15399-15408. 10.1021/la101033n, 20809599.
21. Yin H, Casey P, McCall M. Surface modifications of ZnO nanoparticles and their cytotoxicity. J Nanosci Nanotechnol 2010, 10:7565-7570. 10.1166/jnn.2010.2833, 21137983.
22. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114:1172-1178. 10.1289/ehp.9030, 1552007, 16882521.
23. Oberdorster G, Shart Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445. 10.1080/08958370490439597, 15204759.
24. Yu LE, Yung L-YL, Ong CN, Tan Y-L, Balasubramaniam SS, Hartono D, Shui G, Wenk MR, Ong WY. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotox 2007, 1:235-242.
25. Aschner M. Chapter 8: Nanoparticles: transport across the olfactory epithelium and application to the assessment of brain function in health and disease. Prog Brain Res 2009, 180:141-152.
26. Valdiglesias V, Costa C, Kiliç G, Costa S, Pásaro E, Laffon B, Teixeira J. Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. Environ Int 2013, 55:92-100.
27. Ali J, Ali M, Baboota S, Sahni J, Ramassamy C, Dao L, Bhavna. Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des 2010, 16:1644-1653. 10.2174/138161210791164108, 20210751.
28. Roisen FJ, Kleuber KM, Lu CL, Hatcher LM, Dozier A, Shields CB, Maguire S. Adult human olfactory stem cells. Brain Res 2001, 890:11-22. 10.1016/S0006-8993(00)03016-X, 11164764.
29. Delorme B, Nivet E, Gaillard J, Haupl T, Ringe J, Deveze A, Magnan J, Sohier J, Khrestchatisky M, Roman FS, Charbord P, Sensebe L, Layrolle P, Feron F. The human nose harbours a niche of olfactor ecto-mesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev 2010, 19:853-866. 10.1089/scd.2009.0267, 19905894.
30. Murrell W, Feron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G, Mackay-Sim A. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005, 233:496-515. 10.1002/dvdy.20360, 15782416.
31. Matigian N, Abrahamsen G, Sutharsan R, Cook AL, Vitale AM, Nouwens A, Bellette B, An J, Anderson M, Beckhouse AG, Bennebroek M, Cecil R, Chalk AM, Cochrane J, Fan Y, Feron F, McCurdy R, McGrath JJ, Murrell W, Perry C, Raju J, Ravishankar S, Silburn PA, Sutherland GT, Mahler S, Mellick GD, Wood SA, Sue CM, Wells CA, Mackay-Sim A. Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010, 3:785-798. 10.1242/dmm.005447, 20699480.
32. Albanese A, Tang S, Chan W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012, 14:1-16. 10.1146/annurev-bioeng-071811-150124, 22524388.
33. Feltis B, OKeefe S, Harford A, Piva T, Turney T, Wright P. Independent cytotoxic and inflammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotox 2011, 6:757-765.
34. Stockand J. New ideas about aldosterone signaling in epithelia. Am J Physiol Renal Physiol 2002, 282:F559-F576.
35. Osburn W, Kensler T. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res 2008, 659:31-39. 10.1016/j.mrrev.2007.11.006, 2585047, 18164232.
36. Yin H, Casey P, Coleman V, Moghaddam M, McCall M. A Comparative Study of Physico-Chemical Properties of Commercial, Ultrafine ZnO Particles from Different Batches. International Congress on Safety of Engineered Nanoparticles and Nanotechnologies 2012, Helsinki, Finland, Abstract available in SENN2012 Programme and Abstracts, p47, at http://www.ttl.fi/en/publications/Electronic_publications/Pages/SENN2012.aspx.
37. Pavlica S, Gaunitz F, Gebhardt R. Comparative in vitro toxicity of seven zinc-salts towards neuronal PC12 cells. Toxicol In Vitro 2009, 23:653-659. 10.1016/j.tiv.2009.03.003, 19306923.
38. Turney T, Duriska M, Jayaratne V, Elbaz A, O'Keefe S, Hastings A, Piva T, Wright P, Feltis B. Formation of zinc-containing nanoparticles from Zn2+ ions in cell culture media: Implications for the nanotoxicology of ZnO. Chem Res Toxicol 2012, 25:2057-2066. 10.1021/tx300241q, 22978249.
39. Moos P, Chung K, Woessner D, Honeggar M, Cutler N, Veranth J. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem Res Toxicol 2010, 23:733-739. 10.1021/tx900203v, 20155942.
40. Poynton H, Lazorchak J, Impellitteri C, Smith M, Rogers K, Patra M, Hammer K, Allen H, Vulpe C. Differential gene expression in Daphnia magna suggests distinct modes of action and bioavailability for ZnO nanoparticles and Zn ions. Environ Sci Technol 2011, 45:762-768. 10.1021/es102501z, 21142172.
41. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012, 17:852-870. 10.1007/s10495-012-0705-6, 22395444.
42. Rasheva V, Domingos P. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009, 14:996-1007. 10.1007/s10495-009-0341-y, 19360473.
43. Moos P, Olszewski K, Honeggar M, Cassidy P, Leachman S, Woessner D, Cutler N, Veranth J. Response of human cells to ZnO nanoparticles: a gene transcription study. Metallomics 2011, 3:1199-1211. 10.1039/c1mt00061f, 21769377.
44. Shieh S-Y, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334. 10.1016/S0092-8674(00)80416-X, 9363941.
45. Ng K, Khoo S, Heng B, Setyawati M, Tan E, Zhao X, Xiong S, Fang W, Leong D, Loo J. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011, 32:8218-8225. 10.1016/j.biomaterials.2011.07.036, 21807406.
46. Meyer K, Rajanahalli P, Ahamed M, Rowe J, Hong Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol In Vitro 2011, 25:1721-1726. 10.1016/j.tiv.2011.08.011, 21903158.
47. Cruet-Hennequart S, Gallagher K, Sokòl A, Villalan S, Prendergast A, Carty M. DNA polymerase eta, a key protein in translesion synthesis in human cells. Subcell Biochem 2010, 50:189-209. 10.1007/978-90-481-3471-7_10, 20012583.
48. Osman I, Baumgartner A, Cemeli E, Fletcher J, Anderson D. Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells. Nanomedicine 2010, 5:1193-1203. 10.2217/nnm.10.52, 21039197.
49. Hackenberg S, Simmermann F-Z, Scherzed A, Friehs G, Froelich K, Ginzkey C, Koehler C, Burghatz M, Hagen R, Kleinsasser N. Repetitive exposure to zinc oxide nanoparticles induces DNA damage in human nasal mucosa mini organ cultures. Environ Mol Mutagen 2011, 52:582-589. 10.1002/em.20661, 21786336.
50. Lenz A-G, Karg E, Brendel E, Hinze-Heyn H, Maier K, Eickelberg O, Stoeger T, Schmid O. Inflammatory and oxidative stress responses of an alveolar epithelial cell line to airborne zinc oxide nanoparticles at the air-liquid interface: a comparison with conventional, submerged cell-culture conditions. Biomed Res Int 2013, 2013:652632. 3581099, 23484138.
51. Raemy D, Grass R, Stark W, Schumacher C, Clift M, Gehr P, Rothen-Rutishauser B. Effects of flame made zinc oxide particles in human lung cells - a comparison of aerosol and suspension exposures. Part Fibre Toxicol 2012, 9:33. 10.1186/1743-8977-9-33, 3585858, 22901679.
52. Guilherme J, Kimbell J. Deposition of inhaled nanoparticles in the rat nasal passages: dose to the olfactory region. Inhal Toxicol 2009, 21:1165-1175. 10.3109/08958370902882713, 19831956.
53. NIST National Institute of Standards & Technology. Report of Investigation Reference Material 8012: Gold Nanoparticles, Nominal 30 nm Diameter https://www-s.nist.gov/srmors/view_detail.cfm?srm=8012, NIST.
54. Brunauer S, Emmett PH, Teller E. Adsorption of gases in multimolecular layers. J Am Chem Soc 1938, 60:309-319.
55. Osmond RIW, Das S, Crouch MF. Development of cell-based assays for cytokine receptor signaling, using an AlphaScreen SureFire assay format. Anal Biochem 2010, 403:94-101. 10.1016/j.ab.2010.04.007, 20382104.
56. Leek J, Scharp R, Bravo HC, Simcha D, Langmead B, Johnson W, German D, Baggerly K, Irizarry R. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Gen 2010, 11:733-739.
57. Scherer A. Batch Effects and Noise in Microarray Experiments: Sources and Solutions 2009, Sussex UK: Wiley, Scherer A.
58. Oytam Y. Risk-conscious correction of batch artefacts and multiplicity: Maximising information extraction from high-throughput gene-expression datasets. Bioinformatics Focus on Analytical Methods 2012, Melbourne.
59. Oytam Y. A signals and systems approach to quantifying false discovery rates which is robust against batch noise in throughput genomic datasets. Human Genome Meeting, Genetics and Genomics in Personalised Medicine 2012, Sydney.
60. Cook A, Vitale A, Ravishankar S, Matigan N, Sutherland G, Shan J, Suthersan R, Perry C, Silburn P, Mellick G, Whitelaw M, Wells C, Mackay-Sim A, Wood S. NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic parkinson's disease. PLoS ONE 2011, 6:e21907. 10.1371/journal.pone.0021907, 3128624, 21747966.